GABRIEL LEUNG
CIK 1236183 · EVP & Pres. Pharma. Business · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.05M
Companies
5
Total Filings
79
Lifetime Open-Market Net
-$28.28M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVCR | Director | 101,109 | $17.78 | $1.80M | -$24.16M | 44 | 2026-06-05 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Director | — | — | — | $0 | 3 | 2018-05-23 |
| ALBANY MOLECULAR RESEARCH INC (AMRI) Delisted | Director | 31,316 | — | — | $19.2K | 9 | 2015-03-04 |
| DCTH | Director | 21,485 | $11.72 | $251.8K | $11.8K | 7 | 2014-07-09 |
| OSI PHARMACEUTICALS INC (OSIP) Delisted | EVP & Pres. Pharma. Business | 0 | — | — | -$4.15M | 16 | 2010-06-09 |
Recent Filings · Page 2 of 8
79 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-08 | NVCR | Mixed | — | -$173.1K | EDGAR |
| 2021-05-06 | NVCR | Mixed | — | -$168.2K | EDGAR |
| 2021-04-15 | NVCR | Mixed | — | -$1.00M | EDGAR |
| 2020-09-16 | NVCR | Mixed | — | -$1.76M | EDGAR |
| 2020-09-11 | NVCR | Mixed | — | -$1.54M | EDGAR |
| 2020-09-04 | NVCR | Mixed | — | -$7.8K | EDGAR |
| 2020-08-27 | NVCR | Mixed | — | -$519.9K | EDGAR |
| 2020-08-03 | NVCR | Mixed | — | -$483.4K | EDGAR |
| 2020-07-23 | NVCR | Mixed | — | -$599.0K | EDGAR |
| 2020-06-12 | NVCR | Grant (A) | +2,541 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.